Top

Published in:

01-05-2018 | Original Article

Lymphomas in IgG4-related disease: clinicopathologic features in a Western population

Authors: Jacob R. Bledsoe, Zachary S. Wallace, John H. Stone, Vikram Deshpande, Judith A. Ferry

Published in: Virchows Archiv | Issue 5/2018

Abstract

Lymphomas that occur in the setting of IgG4-related disease (IgG4-RD) are uncommon. Most reported cases derive from Asia and are MALT lymphomas occurring in orbital IgG4-RD. The spectrum of lymphomas among IgG4-RD patients in the Western world remains poorly defined. The aim of this study was to report our experience with lymphomas occurring in IgG4-RD. Eight cases were identified from the pathology and consultation files. The median age was 61 years (range 22–68) at IgG4-RD diagnosis and 63.5 years (range 33–79) at lymphoma diagnosis, with a M:F ratio of 4:4. The diagnosis of lymphoma and IgG4-RD was concurrent in three cases and asynchronous in five (interval 4.3–16.4 years). Concurrent cases included a MALT lymphoma and a diffuse large B cell lymphoma (DLBCL) occurring with IgG4-related sialadenitis and a follicular lymphoma occurring with orbital IgG4-RD. Asynchronous cases included a lymphoplasmacytic lymphoma with large cell transformation and intervening IgG4-related pancreatitis, a MALT lymphoma after lacrimal IgG4-RD, two DLBCLs after multiorgan IgG4-RD, and a DLBCL after IgG4-related sialadenitis. Our findings suggest that lymphomas in IgG4-RD are more varied in location and type than the experience reported from Asia to date. Pathologists should be aware of the potential for lymphoma to develop in patients with IgG4-RD and should have a high degree of suspicion when lymphadenopathy or extranodal masses persist despite appropriate therapy for IgG4-RD. The co-occurrence of IgG4-RD and lymphoma that is reported here and previously suggests a possible etiologic association.

Stone JH, Zen Y, Deshpande V (2012) IgG4-related disease. N Engl J Med 366(6):539–551. https://doi.org/10.1056/NEJMra1104650 CrossRefPubMed

Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S, Stone JH (2015) IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol 67(9):2466–2475. https://doi.org/10.1002/art.39205 CrossRefPubMedPubMedCentral

Deshpande V, Zen Y, Chan JK, et al. (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25(9):1181–1192. https://doi.org/10.1038/modpathol.2012.72

Cheuk W, Chan JK (2012) Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity. Semin Diagn Pathol 29(4):226–234. https://doi.org/10.1053/j.semdp.2012.07.001 CrossRefPubMed

Ferry JA (2013) IgG4-related lymphadenopathy and IgG4-related lymphoma: moving targets. Diagn Histopathol 19(4):128–139. https://doi.org/10.1016/j.mpdhp.2013.01.005 CrossRef

Cheuk W, Yuen HKL, Chu SYY, Chiu EKW, Lam LK, Chan JKC (2008) Lymphadenopathy of IgG4-related sclerosing disease. Am J Surg Pathol 32(5):671–681. https://doi.org/10.1097/PAS.0b013e318157c068 CrossRefPubMed

Asano N, Sato Y (2012) Rheumatoid lymphadenopathy with abundant IgG4(+) plasma cells : a case mimicking IgG4-related disease. J Clin Exp Hematop 52(1):57–61. https://doi.org/10.3960/jslrt.52.57 CrossRefPubMed

Sato Y, Kojima M, Takata K, Morito T, Mizobuchi K, Tanaka T, Inoue D, Shiomi H, Iwao H, Yoshino T (2010) Multicentric Castleman’s disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases. J Clin Pathol 63(12):1084–1089. https://doi.org/10.1136/jcp.2010.082958 CrossRefPubMed

Rollins-Raval MA, Felgar RE, Krasinskas AM, Roth CG (2012) Increased numbers of IgG4-positive plasma cells may rarely be seen in lymph nodes of patients without IgG4-related sclerosing disease. Int J Surg Pathol 20(1):47–53. https://doi.org/10.1177/1066896911420562 CrossRefPubMed

10.

Cheuk W, Yuen HKL, Chan ACL, Shih LY, Kuo TT, Ma MW, Lo YF, Chan WK, Chan JKC (2008) Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol 32(8):1159–1167. https://doi.org/10.1097/PAS.0b013e31816148ad CrossRefPubMed

11.

Sato Y, Ohshima K-I, Ichimura K et al (2008) Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int 58(8):465–470. https://doi.org/10.1111/j.1440-1827.2008.02257.x CrossRefPubMed

12.

Takahashi N, Ghazale AH, Smyrk TC, Mandrekar JN, Chari ST (2009) Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma. Pancreas 38(5):523–526. https://doi.org/10.1097/MPA.0b013e31819d73ca CrossRefPubMed

13.

Yamamoto M, Takahashi H, Tabeya T, Suzuki C, Naishiro Y, Ishigami K, Yajima H, Shimizu Y, Obara M, Yamamoto H, Himi T, Imai K, Shinomura Y (2012) Risk of malignancies in IgG4-related disease. Mod Rheumatol 22(3):414–418. https://doi.org/10.3109/s10165-011-0520-x CrossRefPubMed

14.

Wallace ZS, Wallace CJ, Lu N, Choi HK, Stone JH (2016) Association of IgG4-related disease history of malignancy. Arthritis Rheumatol 68(9):2283–2289. https://doi.org/10.1002/art.39773 CrossRefPubMed

15.

Kubota T, Moritani S, Yoshino T, Nagai H, Terasaki H (2010) Ocular adnexal marginal zone B cell lymphoma infiltrated by IgG4-positive plasma cells. J Clin Pathol 63(12):1059–1065. https://doi.org/10.1136/jcp.2010.082156 CrossRefPubMedPubMedCentral

16.

Swerdlow SH, Campo E, Harris NL et al (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer, Lyon

17.

Ferry JA, Klepeis V, Sohani AR, Harris NL, Preffer FI, Stone JH, Grove A, Deshpande V (2015) IgG4-related orbital disease and its mimics in a Western population. Am J Surg Pathol 39(12):1688–1700. https://doi.org/10.1097/PAS.0000000000000497 CrossRefPubMed

18.

Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Müller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103(1):275–282. https://doi.org/10.1182/blood-2003-05-1545 CrossRefPubMed

19.

Johnson NA, Slack GW, Savage KJ, Connors JM, Ben-Neriah S, Rogic S, Scott DW, Tan KL, Steidl C, Sehn LH, Chan WC, Iqbal J, Meyer PN, Lenz G, Wright G, Rimsza LM, Valentino C, Brunhoeber P, Grogan TM, Braziel RM, Cook JR, Tubbs RR, Weisenburger DD, Campo E, Rosenwald A, Ott G, Delabie J, Holcroft C, Jaffe ES, Staudt LM, Gascoyne RD (2012) Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. J Clin Oncol 30(28):3452–3459. https://doi.org/10.1200/JCO.2011.41.0985 CrossRefPubMedPubMedCentral

20.

Kanda G, Ryu T, Shirai T, Ijichi M, Hishima T, Kitamura S, Bandai Y (2011) Peripheral T-cell lymphoma that developed during the follow-up of IgG4-related disease. Intern Med 50(2):155–160. https://doi.org/10.2169/internalmedicine.50.4413 CrossRefPubMed

21.

Ishida M, Hodohara K, Yoshida K, Kagotani A, Iwai M, Yoshii M, Okuno H, Horinouchi A, Nakanishi R, Harada A, Yoshida T, Okabe H (2013) Occurrence of anaplastic large cell lymphoma following IgG4-related autoimmune pancreatitis and cholecystitis and diffuse large B-cell lymphoma. Int J Clin Exp Pathol 6(11):2560–2568PubMedPubMedCentral

22.

Uehara T, Ikeda S, Hamano H et al (2012) A case of Mikulicz’s disease complicated by malignant lymphoma: a postmortem histopathological finding. Intern Med 51(4):419–423. https://doi.org/10.2169/internalmedicine.51.5713 CrossRefPubMed

23.

Kim T, Grobmyer SR, Dixon LR, Allan RW, Hochwald SN (2008) Autoimmune pancreatitis and concurrent small lymphocytic lymphoma: not just a coincidence? J Gastrointest Surg 12(9):1566–1570. https://doi.org/10.1007/s11605-008-0543-6 CrossRefPubMed

24.

Gupta R, Khosroshahi A, Shinagare S, Fernandez C, Ferrone C, Lauwers GY, Stone JH, Deshpande V (2013) Does autoimmune pancreatitis increase the risk of pancreatic carcinoma?: a retrospective analysis of pancreatic resections. Panceas 42(3):506–510. https://doi.org/10.1097/MPA.0b013e31826bef91 CrossRef

25.

Bledsoe JR, Wallace ZS, Deshpande V, Richter JR, Klapman J, Cowan A, Stone JH, Ferry JA (2017) Atypical plasmacytic proliferations and lymphomas: characterization of 11 cases. Am J Clin Pathol 148(3):215–235. https://doi.org/10.1093/AJCP/AQX067 CrossRefPubMed

26.

Geyer JT, Niesvizky R, Jayabalan DS, Mathew S, Subramaniyam S, Geyer AI, Orazi A, Ely SA (2014) IgG4 plasma cell myeloma: new insights into the pathogenesis of IgG4-related disease. Mod Pathol 27(3):375–381. https://doi.org/10.1038/modpathol.2013.159 CrossRefPubMed

27.

Strehl JD, Hartmann A, Agaimy A (2011) Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol 64(3):237–243. https://doi.org/10.1136/jcp.2010.085613 CrossRefPubMed

28.

Menon MP, Evbuomwan MO, Rosai J, Jaffe ES, Pittaluga S (2014) A subset of Rosai-Dorfman disease cases show increased IgG4-positive plasma cells: another red herring or a true association with IgG4-related disease? Histopathology 64(3):455–459. https://doi.org/10.1111/his.12274 CrossRefPubMed

Title: Lymphomas in IgG4-related disease: clinicopathologic features in a Western population
Authors: Jacob R. Bledsoe
Zachary S. Wallace
John H. Stone
Vikram Deshpande
Judith A. Ferry
Publication date: 01-05-2018
Publisher: Springer Berlin Heidelberg
Published in: Virchows Archiv / Issue 5/2018
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-017-2286-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Lymphomas in IgG4-related disease: clinicopathologic features in a Western population

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2018

In papillary thyroid carcinoma, expression by immunohistochemistry of BRAF V600E, PD-L1, and PD-1 is closely related

LIMK/cofilin pathway and Slingshot are implicated in human colorectal cancer progression and chemoresistance

Progression of urothelial carcinoma in situ of the urinary bladder: a switch from luminal to basal phenotype and related therapeutic implications

Book Review—Diagnostic Pathology: Lymph Nodes and Extranodal Lymphomas, 2nd Edition

Metastatic non-small cell lung carcinoma a mimic of primary breast carcinoma—case series and literature review

Role of ancillary techniques in profiling unclassified laryngeal malignancies